Anticholinergic use is associated with lower mortality but not increased hip fracture risk in Parkinson’s disease patients: a retrospective cohort study

Anticholinergic use is associated with lower mortality but not increased hip fracture risk in Parkinson’s disease patients: a retrospective cohort study

Abstract Background It is unclear whether antiparkinsonism anticholinergics (AAs) increase hip fracture (HFx) risk in Parkinson’s disease (PD) patients. This study examined associations between AAs, HFx and mortality in PD using Taiwan’s National Health Insurance Database. Methods Newly diagnosed PD...

Full description

Saved in:
Bibliographic Details
Main Authors: Po-Yen Ko, Po-Ting Wu, I-Ming Jou, Renin Chang, Ching-Hou Ma
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Geriatrics
Subjects:
Antiparkisonism anticholinergic agent
Parkinson’s disease
Hip fracture
Survival rate
Cohort study
Online Access:https://doi.org/10.1186/s12877-024-05535-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items